You are here
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
SBC: TRANSPARENT ARMOR SOLUTIONS INC. Topic: A14AT017
Our nation’s warfighters require advanced armor to give them the best protection while allowing mobility to perform their missions. This proposal will develop two powerful tools to aid future body armor advancements. First, this research program will develop a statistical analysis software that will predict likelihood of impacts based on defined attack scenarios (i.e. rifle, distance and firing ...STTR Phase II 2018 Department of DefenseArmy
SBC: SA PHOTONICS, LLC Topic: AF17AT011
A Battlefield Airman (BA) has one of the most challenging positions in the military. BA personnel are tasked with the dual roles of being warfighters as well as Combat Controllers, Pararescuemen, Tactical Air Control Party (TACP) members and Special Operations Weather Technicians often while behind enemy lines. These complex duties require high fidelity training. In some cases, such as Pararescuem ...STTR Phase II 2018 Department of DefenseAir Force
SBC: MAPP BIOPHARMACEUTICAL, INC. Topic: CBD18A002
There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
Analysis and Application of Treatments to Mitigate Exfoliation Corrosion (Delamination) of 5XXX Series AluminumSBC: OCEANIT LABORATORIES INC Topic: N18AT016
Oceanit proposes to research and develop chemical or non-chemical methods and processes to impart surface morphology modifications to aluminum-magnesium (Al-Mg) alloys to mitigate and increase the exfoliation corrosion resistance.STTR Phase I 2018 Department of DefenseNavy
SBC: Integrated Solutions for Systems, Inc. Topic: A17AT017
Integrated Solutions for Systems, Inc. (IS4S) and teammate Auburn University (AU) propose to develop a PNT initialization system for dismounted soldiers. The proposed system will enhance warfighters’ ability to operate immediately in a GPS denied environments once their mission begins and has wide commercialization potential outside of DoD. In Phase I, the feasibility and expected benefits of in ...STTR Phase II 2018 Department of DefenseArmy
SBC: LONGWAVE PHOTONICS LLC Topic: A17AT007
The Tunable Active HEterodyne Terahertz Imager (TAHETI) system will use Terahertz Quantum-Cascade Lasers (QCL) combined with a Schottky diode detector for ultra-high dynamic range heterodyne imaging. Distributed feedback (DFB) QCLs with milliwatt power levels are engineered to emit at slightly offset frequencies, and are used as local oscillator and illumination for imaging. The QCLs will be down ...STTR Phase II 2018 Department of DefenseArmy
SBC: Flow Pharma, Inc. Topic: CBD18A002
Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
SBC: PATHOVACS INCORPORATED Topic: CBD18A001
The focus of this STTR phase I component is on proof-of-concept studies demonstrating applicability of technical approaches for identificationof circulatory diagnostic markers for infectious disease. Therefore, the primary objective of this project is to determine feasibility of one suchtechnical approach called Proteomics-based Expression Library Screening (PELS), for identification of pathogen-d ...STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
SBC: CFD RESEARCH CORPORATION Topic: CBD18A001
In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
SBC: ATTOLLO ENGINEERING, LLC Topic: AF16AT22
Current scene projection hardware is challenged to simultaneously meet the requirements for high peak temperature (> 2000K), high resolution (2Kx2K), response time < 4 ms, cryogenic and temporally uniform photon flux. MEMS, Resistor arrays, liquid crystals, and photonic crystals all suffer in one or more areas. MEMS suffer from flicker and low dynamic range. Resistor arrays suffer from low frame r ...STTR Phase II 2018 Department of DefenseAir Force